Search - tctmd.com

Displaying 21 - 40 of 44

Sort: Relevancy | Date

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

News Features

Keeping Up With Cardiology: Old-School Learning Versus the Twittersphere

Yael L. Maxwell

August 02, 2018

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

L.A. McKeown

February 26, 2018

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Features

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Caitlin E. Cox

June 14, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

News Features

Be It Resolved: E-Cigarettes May Help Smokers Cut Back, but Quit Altogether? The Jury’s Out

Caitlin E. Cox

January 20, 2017

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Todd Neale

June 27, 2016

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

News Features

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Caitlin E. Cox

March 21, 2016

News Features

Future of Renal Denervation May Hinge on a Handful of Small Studies

Todd Neale

February 14, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Features

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

Yael L. Maxwell

November 01, 2015

News Features

Trials Prompt Interventionalists to Reconsider Complete Revascularization for STEMI

Kim Dalton

March 09, 2015

News Features

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

L.A. McKeown

January 28, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

Advertisement

Top News in Coronary Artery Disease: 2018

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Keeping Up With Cardiology: Old-School Learning Versus the Twittersphere

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Be It Resolved: E-Cigarettes May Help Smokers Cut Back, but Quit Altogether? The Jury’s Out

The Bioresorbable Stent Story So Far: What Promise? What Price?

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Future of Renal Denervation May Hinge on a Handful of Small Studies

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

Trials Prompt Interventionalists to Reconsider Complete Revascularization for STEMI

Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content